Agios Pharma (AGIO) Investment Meetings Prove Company is Hitting Its Stride - Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren reiterated an Overweight rating and $80.00 price target on Agios Pharma (NASDAQ: AGIO) citing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
